HP
Hikari Power Portfolio holdings
AUM
$1.2B
This Quarter Return
-1.82%
1 Year Return
+14.18%
3 Year Return
+56.59%
5 Year Return
+122.08%
10 Year Return
+191.59%
AUM
$1.11B
AUM Growth
+$1.11B
(-4.8%)
Cap. Flow
-$30.1M
Cap. Flow
% of AUM
-2.72%
Top 10 Holdings %
Top 10 Hldgs %
75.65%
Holding
63
New
–
Increased
1
Reduced
4
Closed
1
Top Buys
| 1 |
Veeva Systems
VEEV
|
$134K |
Top Sells
| 1 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$493K |
| 2 |
Cigna
CI
|
$142K |
| 3 |
Fortive
FTV
|
$66.7K |
Sector Composition
| 1 | Financials | 52.49% |
| 2 | Healthcare | 17.62% |
| 3 | Materials | 8.07% |
| 4 | Energy | 7.76% |
| 5 | Technology | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
MetLife
MET
$54.1B
| $743K | 0.07% | 10,580 | – | – |
|
52
IDEX
IEX
$12.4B
| $545K | 0.05% | 2,710 | – | – |
|
|
53
Veeva Systems
VEEV
$44B
| $500K | 0.05% | 2,730 +730 | +37% | +$134K |
|
54
Brookfield
BN
$98.3B
| $415K | 0.04% | 10,000 | – | – |
|
55
Anavex Life Sciences
AVXL
$828M
| $361K | 0.03% | 85,585 | – | – |
|
56
Vanguard High Dividend Yield ETF
VYM
$64B
| $288K | 0.03% | 2,430 | – | – |
|
57
US Bancorp
USB
$76B
| $210K | 0.02% | 5,300 | – | – |
|
58
Ocular Therapeutix
OCUL
$2.12B
| $116K | 0.01% | 17,000 | – | – |
|
59
Corvus Pharmaceuticals
CRVS
$428M
| $91K | 0.01% | 49,959 | – | – |
|
60
Aldeyra Therapeutics
ALDX
$351M
| $66K | 0.01% | 20,020 | – | – |
|
|
ALPN
61
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| – | – | -12,445 | Closed | -$493K |
|